Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach

Dietary Bioactive Diindolylmethane Enhances the Therapeutic Efficacy of Centchroman in Breast Cancer Cells by Regulating ABCB1/P-gp Efflux Transporter

(2021) Dhanamjai Penta et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Silibinin induces metabolic crisis in triple‐negative breast cancer cells by modulating EGFR‐MYC‐TXNIP axis: potential therapeutic implications

(2020) Mohammad Askandar Iqbal et al.   FEBS Journal

Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis

(2020) Sajid Khan et al.   LIFE SCIENCES

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

(2020) Yue Gong et al.   Cell Metabolism

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

(2019) Karen G. de la Cruz-López et al.   Frontiers in Oncology

Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis

(2018) Jayant Dewangan et al.   LIFE SCIENCES

Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition

(2018) Farid Ahmad Siddiqui et al.   Scientific Reports

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

(2017) Carsten Denkert et al.   LANCET

LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells

(2016) Almut Brand et al.   Cell Metabolism

Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies

(2016) Cynthia A. Thomson et al.   NUTRITION REVIEWS

Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling

(2015) Sajid Khan et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer

(2015) Sajid Khan et al.   MOLECULAR CARCINOGENESIS

Natural Compounds Regulate Glycolysis in Hypoxic Tumor Microenvironment

(2015) Jian-Li Gao et al.   Biomed Research International

Anti-Cancer Potential of a Novel SERM Ormeloxifene

(2013) Rishi Gara et al.   CURRENT MEDICINAL CHEMISTRY

bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses

(2013) P. Jezequel et al.   Database-The Journal of Biological Databases and Curation

Glucose transporters in cancer metabolism

(2012) Kehinde Adekola et al.   CURRENT OPINION IN ONCOLOGY

Delineating metabolic signatures of head and neck squamous cell carcinoma: Phospholipase A2, a potential therapeutic target

(2012) Pratima Tripathi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications

(2012) Syed M. Meeran et al.   PLoS One

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

(2011) Pascal Jézéquel et al.   BREAST CANCER RESEARCH AND TREATMENT

Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1

(2011) Weibo Luo et al.   CELL

How the 1D-NOESY suppresses solvent signal in metabonomics NMR spectroscopy: An examination of the pulse sequence components and evolution

(2011) Ryan T. Mckay   CONCEPTS IN MAGNETIC RESONANCE PART A

Magic Angle Spinning NMR-Based Metabolic Profiling of Head and Neck Squamous Cell Carcinoma Tissues

(2011) Bagganahalli S. Somashekar et al.   JOURNAL OF PROTEOME RESEARCH

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

(2011) Weiwei Yang et al.   NATURE

Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines

(2010) Syed M. Meeran et al.   PLoS One

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

3,3′-Diindolylmethane reduces levels of HIF-1α and HIF-1 activity in hypoxic cultured human cancer cells

(2008) Jacques E. Riby et al.   BIOCHEMICAL PHARMACOLOGY

Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3,3'-Diindolylmethane in Healthy Subjects

(2008) G. A. Reed et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Pyruvate kinase M2 is a phosphotyrosine-binding protein

(2008) Heather R. Christofk et al.   NATURE

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

(2008) Heather R. Christofk et al.   NATURE